Legislation sponsored by State Representative Norine Hammond to expand the scope of ovarian cancer screenings has passed the Illinois House.
House Bill 4203 adds having a high level of CA-125, as indicated by a blood test screening, to the definition of “at risk for ovarian cancer.” It provides that “surveillance tests for ovarian cancer” means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood test screenings.
“Assuring access to high-quality health care and cancer screenings has always been one of my top priorities,” Rep. Hammond said. “This legislation ensures that CA-125 blood test screenings for those at risk for ovarian cancer will be covered by health insurance plans.”
HB 4203 was unanimously approved by the Illinois House on Tuesday and advanced to the Senate for further consideration.